Early de-escalation of DAPT after PCI: implications of the latest randomized trials in the COVID era

Indian Heart J. 2020 May-Jun;72(3):209-211. doi: 10.1016/j.ihj.2020.05.009. Epub 2020 May 23.
No abstract available

Keywords: COVID-19; Coronavirus; Descalation; Dual antiplatelet therapy.

Publication types

  • Letter
  • Review

MeSH terms

  • Betacoronavirus*
  • COVID-19
  • Coronary Artery Disease / complications
  • Coronary Artery Disease / epidemiology
  • Coronary Artery Disease / therapy*
  • Coronavirus Infections / complications*
  • Coronavirus Infections / epidemiology
  • Drug-Eluting Stents
  • Global Health
  • Humans
  • Morbidity / trends
  • Pandemics
  • Percutaneous Coronary Intervention / methods*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / epidemiology
  • Randomized Controlled Trials as Topic*
  • SARS-CoV-2
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors